TURNING POINT THERAPEUTICS I's ticker is TPTX and the CUSIP is 90041T108. A total of 156 filers reported holding TURNING POINT THERAPEUTICS I in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $67,000 | +179.2% | 895 | 0.0% | 0.05% | +237.5% |
| Q1 2022 | $24,000 | -44.2% | 895 | 0.0% | 0.02% | -40.7% |
| Q4 2021 | $43,000 | -41.9% | 895 | -19.7% | 0.03% | -50.0% |
| Q3 2021 | $74,000 | +21.3% | 1,114 | +41.4% | 0.05% | +20.0% |
| Q2 2021 | $61,000 | +1425.0% | 788 | +1732.6% | 0.04% | +1400.0% |
| Q1 2021 | $4,000 | -50.0% | 43 | -34.8% | 0.00% | -57.1% |
| Q4 2020 | $8,000 | -76.5% | 66 | -83.2% | 0.01% | -77.4% |
| Q3 2020 | $34,000 | +580.0% | 393 | +417.1% | 0.03% | +520.0% |
| Q2 2020 | $5,000 | – | 76 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| venBio Partners LLC | 708,233 | $44,116,000 | 18.91% |
| Corriente Advisors, LLC | 285,000 | $17,753,000 | 9.54% |
| Cormorant Asset Management, LP | 3,396,650 | $211,577,000 | 8.44% |
| Opaleye Management Inc. | 340,500 | $21,210,000 | 4.16% |
| Orbimed Advisors | 2,745,327 | $171,006,000 | 2.44% |
| Parkman Healthcare Partners LLC | 101,434 | $6,318,000 | 1.82% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 35,000 | $2,179,000 | 0.78% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 366,000 | $22,798,000 | 0.73% |
| Artal Group S.A. | 300,000 | $18,687,000 | 0.72% |
| DAFNA Capital Management LLC | 30,408 | $1,894,000 | 0.65% |